These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10462751)

  • 1. Hepatitis C virus: current understanding and prospects for future therapies.
    Rosen HR; Gretch DR
    Mol Med Today; 1999 Sep; 5(9):393-9. PubMed ID: 10462751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis, diagnosis and management of hepatitis C.
    Boyer N; Marcellin P
    J Hepatol; 2000; 32(1 Suppl):98-112. PubMed ID: 10728798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Future trends in managing hepatitis C.
    McHutchison JG; Dev AT
    Gastroenterol Clin North Am; 2004 Mar; 33(1 Suppl):S51-61. PubMed ID: 15081103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and evolving therapies for hepatitis C.
    Moradpour D; Blum HE
    Eur J Gastroenterol Hepatol; 1999 Nov; 11(11):1199-202. PubMed ID: 10563526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic hepatitis C.
    Sharara AI
    South Med J; 1997 Sep; 90(9):872-7. PubMed ID: 9305294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New therapies on the horizon for hepatitis C: are we close?
    De Francesco R; Rice CM
    Clin Liver Dis; 2003 Feb; 7(1):211-42, xi. PubMed ID: 12691468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus-specific immune responses and quasi-species variability at baseline are associated with nonresponse to antiviral therapy during advanced hepatitis C.
    Morishima C; Polyak SJ; Ray R; Doherty MC; Di Bisceglie AM; Malet PF; Bonkovsky HL; Sullivan DG; Gretch DR; Rothman AL; Koziel MJ; Lindsay KL;
    J Infect Dis; 2006 Apr; 193(7):931-40. PubMed ID: 16518754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Viral hepatitis C].
    Zeuzem S; Roth WK; Herrmann G
    Z Gastroenterol; 1995 Feb; 33(2):117-32. PubMed ID: 7536996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate and adaptive immune responses in HCV infections.
    Heim MH; Thimme R
    J Hepatol; 2014 Nov; 61(1 Suppl):S14-25. PubMed ID: 25443342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C: therapeutic perspectives.
    Cornberg M; Wedemeyer H; Manns MP
    Forum (Genova); 2001; 11(2):154-62. PubMed ID: 11948360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection.
    Lehmann M; Meyer MF; Monazahian M; Tillmann HL; Manns MP; Wedemeyer H
    J Med Virol; 2004 Jul; 73(3):387-91. PubMed ID: 15170633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of interleukin-8 in hepatitis C virus infection: relation to combined peg-interferon ribavirin response and genotype 4.
    El Sayed ZM; Mansour FA; Ghal MF; Abou-Zahra SB
    Immunol Invest; 2011; 40(1):29-38. PubMed ID: 20809700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus: prospects for future therapies.
    Wilkinson T
    Curr Opin Investig Drugs; 2001 Nov; 2(11):1516-22. PubMed ID: 11763151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replicative homeostasis III: implications for antiviral therapy and mechanisms of response and non-response.
    Sallie R
    Virol J; 2007 Mar; 4():29. PubMed ID: 17355620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New therapeutic options for HCV infection in the monoclonal antibody era.
    Sautto GA; Diotti RA; Clementi M
    New Microbiol; 2012 Oct; 35(4):387-97. PubMed ID: 23109006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up after successful interferon therapy of acute hepatitis C.
    Wiegand J; Jäckel E; Cornberg M; Hinrichsen H; Dietrich M; Kroeger J; Fritsch WP; Kubitschke A; Aslan N; Tillmann HL; Manns MP; Wedemeyer H
    Hepatology; 2004 Jul; 40(1):98-107. PubMed ID: 15239091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inter and intrapatient evolution of hepatitis C virus.
    Di Lello FA; Culasso AC; Campos RH
    Ann Hepatol; 2015; 14(4):442-9. PubMed ID: 26019029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of hepatitis G virus infection on the severity of liver disease and response to interferon-alpha in patients with chronic hepatitis C.
    Martinot M; Marcellin P; Boyer N; Detmer J; Pouteau M; Castelnau C; Degott C; Aupérin A; Collins M; Kolberg J; Wilber J; Benhamou JP; Erlinger S
    Ann Intern Med; 1997 Jun; 126(11):874-81. PubMed ID: 9163288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quasispecies in viral persistence and pathogenesis of hepatitis C virus.
    Forns X; Purcell RH; Bukh J
    Trends Microbiol; 1999 Oct; 7(10):402-10. PubMed ID: 10498948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.